Introduction
============

Skeletal muscle is a unique tissue for many reasons, the most striking of which is that its cells are multi-nucleated (i.e., syncytial). Further, as skeletal muscle nuclei are post-mitotic, there is a reliance on the dedicated myogenic stem cell population, called satellite cells, to fuse into the syncytium for the purposes of myonuclear addition or possibly replacement. These properties make satellite cells essential for post-natal muscle growth and muscle fiber regeneration after injury ([@B71]; [@B42]; [@B47]; [@B59]; [@B69]). Following the discovery of satellite cells ([@B68]; [@B37]; [@B45]), scientists postulated that a given myonucleus can only transcriptionally govern a fixed volume of cytoplasm, or "myonuclear domain" ([@B8]; [@B29]; [@B63]). This hypothesis was reinforced by early experiments in rodents that indicated load-induced hypertrophy was accompanied by myonuclear accretion ([@B70]).

The myonuclear domain theory in skeletal muscle can be traced back to the work of Dr. Charles Epstein, who reported that cell size was directly proportional to gene dosage in polyploidy liver cells ([@B18]). Incidentally, hepatocytes have a marked capacity for hypertrophy without DNA synthesis ([@B60]; [@B49]), and resident hepatocyte nuclei can transcriptionally support at least a doubling in cell size ([@B38]). The idea of a rigid nuclear domain is nevertheless ascribed to highly plastic, multi-nucleated skeletal muscle fibers and is pervasive and engrained within the context of skeletal muscle fiber hypertrophy. The controversy surrounding this idea is evidenced by a recent debate regarding the necessity of satellite cell-mediated myonuclear accretion for loading-induced hypertrophy ([@B17]; [@B46]), as well as recent studies supporting the existence of a rigid myonuclear domain during hypertrophy ([@B16]; [@B27]; [@B31]; [@B51]; [@B67]). The purpose of this *Mini Review* is to provide perspective on myonuclear domain flexibility in skeletal muscle fibers during hypertrophy. We will discuss recent examples of myonuclear domain flexibility, specifically in fast-twitch Type 2 fibers of humans and rodents, and highlight the emerging role of satellite cells as key mediators of extracellular matrix remodeling during adult muscle fiber growth.

Evidence for Myonuclear Domain Flexibility During Hypertrophy
=============================================================

Adult humans, mice, and rats have nearly identical myonuclear domain sizes ([@B43]). Numerous studies in humans and rodents report that satellite cell proliferation and myonuclear accretion occurs with skeletal muscle fiber hypertrophic growth (reviewed in [@B77]; [@B54]). The often-observed incidence of large muscle fibers with a high proportion of myonuclei after training reinforces the notion that the myonuclear domain may expand modestly ([@B9]), but generally remains stable during hypertrophy (Scenario A in **Figure [1](#F1){ref-type="fig"}**). Muscle fiber hypertrophy and myonuclear accretion via testosterone supplementation further implies that myonuclear accretion directly contributes to adult muscle growth ([@B73]; [@B15]). Conversely, time-course studies in rats ([@B78]) and humans ([@B36]) show a substantial degree of loading-induced muscle fiber hypertrophy can occur prior to or in the absence of myonuclear accretion, resulting in significant expansion of the myonuclear domain.

![Flow chart describing the different perspectives on satellite cell-mediated myonuclear accretion and myonuclear domain expansion during Type 2 fiber hypertrophy across species. In scenario **(A)**, the myonuclear domain expands modestly until an upper limitation is reached, and then satellite cell-mediated myonuclear accretion ensues to support further hypertrophy. Evidence for this scenario is found in humans and rodents. In scenario **(B)**, satellite cell density increases in the absence of myonuclear accretion, and the myonuclear domain expands significantly or indefinitely as hypertrophy progresses. An upper limit in the myonuclear domain has not yet been identified. Evidence for this scenario is found primarily in rodent models, but significant hypertrophy without myonuclear accretion in humans has been reported. In scenario **(C)**, satellite cell-mediated myonuclear accretion precedes hypertrophy and is absolutely required for growth, implying that the myonuclear domain is tightly regulated. This scenario may apply to immature, growing skeletal muscle, but the evidence is limited in adult muscle.](fphys-09-00635-g001){#F1}

Type 1 and 2 muscle fibers demonstrate differential hypertrophic plasticity under a wide variety conditions in humans ([@B44]; [@B56], [@B55]), and myonuclear domain flexibility during hypertrophy accordingly seems to differ by fiber type. Our laboratory ([@B25]) and others ([@B30]; [@B11]) showed that the myonuclear domain of human Type 2 muscle fibers, which comprise ∼50% of muscle fibers in most muscles, is highly flexible. [@B30] reported Type 2 fiber hypertrophy \> 30% with non-statistically significant myonuclear accretion (9.5%, *P* \< 0.10) and a 29% expansion of the myonuclear domain after resistance training in untrained women. These findings do not necessarily rule out the existence of a "myonuclear domain ceiling", but do challenge the idea of a muscle fiber growth "threshold" beyond which myonuclear accretion is theoretically required to sustain hypertrophy ([@B36]; [@B64]; [@B9]). This threshold was derived most recently from correlations in human work and, while translational outcomes in humans are the ultimate goal, loss-of-function studies in mice are necessary to complement the indirect, correlative evidence gained in humans and to determine causality. It has also been proposed that differences between "low" and "high" hypertrophic responders to resistance training was explained by the extent of myonuclear accretion ([@B64], [@B65]), but this has recently been challenged in the literature by evidence showing myonuclear accretion is uncoupled from muscle fiber hypertrophy ([@B50]). We acknowledge that baseline myonuclear density and/or fiber size could influence the requirement for myonuclear accretion during hypertrophy ([@B75]), but it should be noted that identifying *bona fide* myonuclei on histological cross sections (the prevailing method) is somewhat subjective. The absolute number of myonuclei in a muscle fiber is dependent on the assessor's interpretation of whether the central mass of a nucleus is inside or outside of a dystrophin border, which is highly contingent on the quality of staining and the experience of the technician. This ambiguity makes it difficult to compare absolute values across laboratories. The development of an antibody against the myonuclear marker PCM-1 may help resolve this issue ([@B81]).

Genetically modified mouse models provide overwhelming evidence for Type 2 fiber-specific hypertrophy in the absence of myonuclear accretion (Scenario B in **Figure [1](#F1){ref-type="fig"}**). Following conditional genetic deletion of satellite cells, our laboratory reports substantial hypertrophy in the plantaris muscle, primarily composed of Type 2 fibers, following synergist ablation surgery in adult mice (\>4 months old) ([@B47], [@B46]; [@B24], [@B23]; [@B39]; [@B58], [@B54]). Importantly, the lack of myonuclear accretion during hypertrophy does not negatively affect single muscle fiber contractile function ([@B47]; [@B24]). Furthermore, resident myonuclei possess a significant transcriptional reserve that compensates for a lack of satellite cells during Type 2 fiber hypertrophy ([@B39]). A maximal transcriptional rate for a given myonucleus that corresponds to a specific myonuclear domain size has yet to be identified. Manipulating signaling pathways that are central to muscle fiber size regulation (e.g., Myostatin, AKT, JunB), in the absence of muscle overload or damage, also induces significant hypertrophy without myonuclear accretion and provides further evidence for myonuclear domain flexibility in Type 2 muscle fibers ([@B80]; [@B1]; [@B3]; [@B66]; [@B41]; [@B79]; [@B62]). Interestingly, when Type 2 fibers are genetically modified to be more oxidative, hypertrophy is associated with myonuclear accretion ([@B62]); this dovetails with human data showing oxidative Type 1 fiber hypertrophy from exercise is accompanied by increased myonuclear density ([@B25]). More work is needed to determine whether increased biosynthetic activity associated with the high metabolic demands of oxidative muscle fibers influences fiber type-specific requirements for myonuclear accretion during hypertrophy. Alternative non-surgical methods of inducing hypertrophy in muscles other than the plantaris in mice will likely be required to address this question.

Limited Evidence for Prerequisite Myonuclear Accretion to Support Adult Muscle Fiber Hypertrophy
================================================================================================

It is clear that the myonuclear domain is more flexible than previously appreciated, but some evidence suggests that myonuclear accretion is absolutely required for, and in fact precedes hypertrophy (Scenario C in **Figure [1](#F1){ref-type="fig"}**). Type 2 fibers in young mice (\<4 months old) appear to have an absolute requirement for myonuclear accretion to mount a hypertrophic response ([@B28]; [@B16]; [@B27]; [@B31]; [@B67]) which, as noted above, is not the case in full-grown adult mice ([@B47]; [@B24], [@B23]; [@B39]; [@B58]). The evidence for myonuclear accretion and contraction of the myonuclear domain preceding hypertrophy is very limited ([@B7]). Additionally, significant myonuclear accretion ensues in response to non-hypertrophic stimuli such as heavy endurance training ([@B21], [@B22]; [@B48]), which is antithetical to the position that myonuclear accretion drives hypertrophy. This is especially salient since myonuclear accretion is not necessary for oxidative adaptations to endurance training ([@B33]), even in the highly-active diaphragm muscle ([@B53]).

The effects of anabolic steroid usage provide circumstantial evidence that myonuclear accretion facilitates hypertrophy. Supraphysiological testosterone levels elicit hypertrophy in conjunction with myonuclear addition ([@B73]; [@B15]), which is compounded during heavy resistance training and pronounced hypertrophy ([@B35]; [@B19]). However, androgen signaling can increase myogenic cell proliferation and differentiation *in vitro* and *in vivo* ([@B40]; [@B26]; [@B72]; [@B13]), making it difficult to tease out the contribution of testosterone-directed fusion versus inflammation/damage versus hypertrophy on myonuclear accretion. Recent evidence also suggests that an inflammatory environment alone causes myonuclear accretion in the absence of exercise training and altered muscle fiber size ([@B4]). We interpret these findings to mean that satellite cell fusion to muscle fibers *in vivo* can be mediated solely by the signaling milieu and uncoupled from muscle fiber size. During short-term muscle atrophy induced by hind limb suspension in mice, the myonuclear domain is dramatically reduced in size, further demonstrating the flexibility of the myonuclear domain ([@B6]; [@B5]; [@B34]; [@B54]). That is to say, if the myonuclear domain were truly rigid, one may expect myonuclear loss to consistently scale with atrophy in order to maintain the myonucleus-to-protein ratio, which would be consistent with the original "DNA unit" concept that is the foundation of the myonuclear domain theory ([@B8]). Worth noting is that the duration of unloading, as well as the species and muscle under investigation, can produce differing results regarding myonuclear loss during unloading (reviewed in [@B54]). Since atrophy and hypertrophy are distinct processes, more work is needed to determine whether prerequisite myonuclear accretion is required for regrowth after unloading in instances where myonuclei are lost during atrophy ([@B61]; [@B74]; [@B14]).

Perspectives on the Early Satellite Cell Response to Resistance Exercise
========================================================================

Following severe muscle fiber injury, satellite cells mediate skeletal muscle regeneration via myogenesis and interactions with fibroblasts to coordinate proper extracellular matrix remodeling ([@B59]). Resistance exercise in humans is not typically associated with muscle degeneration, but muscle injury, inflammation, and sarcolemmal damage may ensue ([@B12]). One hypothesis is that the magnitude of early satellite cell proliferation after unaccustomed resistance exercise reflects myonuclear accretion potential and predicts hypertrophic adaptation; however, the relationship to muscle fiber growth is unclear ([@B2]). Once muscle damage subsides, satellite cell proliferation after resistance exercise is attenuated ([@B57]; [@B11]), and is not predictive of the ∼16% Type 2 muscle fiber growth reported by [@B11]. Consistent with initial conjectures on early satellite cell proliferation with overload ([@B76]), it seems that muscle fiber damage and satellite cell niche disruption primarily dictates satellite cell responses to resistance exercise, and not hypertrophy *per se*. The relationship between exercise-mediated muscle fiber damage and satellite cell proliferation is underscored by greater satellite cell density after highly- versus minimally-damaging contractions in exercise-naïve men ([@B10]; [@B32]).

Under certain conditions, the propensity to fuse is an inherent property of activated satellite cells ([@B52]). As such, it is conceivable that satellite cell-mediated myonuclear accretion observed with resistance training is simply a response to muscle fiber damage and the accompanying milieu, and not a requirement to maintain myonuclear domain size. In support of this hypothesis, Type 2 fiber myonuclear accretion occurs during 12 weeks of eccentric (i.e., damaging) but not concentric (i.e., minimally damaging) resistance training, despite similarly modest hypertrophic responses to both modes ([@B20]). The most strenuous exercise may induce the most damage, and subsequently the most myonuclear accretion. Worth mentioning is that the synergist ablation model of skeletal muscle overload used to induce hypertrophy in rodents can be rather severe and damage-inducing depending on how the surgery is conducted ([@B76]), which is an obvious drawback of the model that may affect translatability to humans. Nevertheless, muscle fibers can hypertrophy successfully without satellite cells using this extreme model, and in the absence of degeneration--regeneration ([@B47]). Interestingly, our laboratory recently showed that the early satellite cell proliferative response to mechanical loading is crucial for proper extracellular matrix remodeling during hypertrophy ([@B23]). Instead of myonuclear addition to muscle fibers, we suggest that the critical role for activated satellite cells in response to a hypertrophic stimulus is to participate in extracellular matrix remodeling which ulitmately facilitates growth, at least in Type 2 fibers ([@B24], [@B23]; [@B54]).

Conclusion
==========

The role of satellite cells during hypertrophy extends beyond myonuclear accretion. Significant myonuclear domain flexibility is apparent in human and rodent muscle fibers during growth, which is most evident in Type 2 fibers. Satellite cells play an important role in the hypertrophic process, and we cannot rule out that myonuclear accretion may be necessary for hypertrophy under some conditions. However, we contend that satellite cell proliferation with loading, particularly in early phases but potentially throughout training, is likely for the purposes of supporting muscle repair and extracellular matrix remodeling, and not necessarily a precursor to fusion for augmenting transcriptional capacity during adult muscle fiber hypertrophy. The critical function of satellite cells in regulating the extracellular environment, but not necessarily driving growth via myonuclear accretion, can be leveraged to help guide therapeutics aimed at preserving or enhancing muscle mass and function. More work is needed to determine the upper limit of myonuclear domain flexibility and mechanisms regulating transcriptional reserve capacity, as well as the extent to which Type 1 fibers can grow without myonuclear accretion.
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